Plus Vitech SL (PVT)is a newly created innovative SME, which focuses on the development and validation of a new strategy for diagnosis and treatments in cancer.
The cancer is the epidemic of the XXI century. 1 of 3 people will suffer from cancer. With the current treatments, only 40% will survive. Cancer is a very elusive illness: Each type is different and evolves in every person over time.
Our technology is based on a specific protein receptor of the tumor cells. That protein plays an important role in cancer´s cells survival and progression. Furthermore, it is different in tumor and normal cells. These properties offer an opportunity to develop a highly effective and specific cancer treatment and develop a robust diagnostic method.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it :)Yeah, OkRead more